Impact of COVID-19 side-effects on pediatric and adult patients with recurrent wheeze and asthma
Nicole Maison(Center for Environmental Health), Jimmy Omony(Helmholtz Munich), Matthias Kopp(German Center for Lung Research), Christina Schauberger, Ruth Grychtol(Medizinische Hochschule Hannover), Klaus F. Rabe(Christian-Albrechts-Universität zu Kiel), Erika von Mutius(German Center for Lung Research), Bianca Schaub(LMU Klinikum), Heidrun Herbrüggen(German Center for Lung Research), Gesine Hansen(Medizinische Hochschule Hannover), Mustafa Abdo(Heidelberg University), Henrik Watz(University of Lübeck), Thomas Bahmer(Christian-Albrechts-Universität zu Kiel), Wilfried H. Nikolaizik(Philipps University of Marburg), Svenja Foth(Philipps University of Marburg)
Cited by 0
Related Papers
Exposure to Environmental Microorganisms and Childhood Asthma
|New England Journal of Medicine|2011|1.5k
Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
|American Journal of Respiratory and Critical Care Medicine|2010|1k
Outcomes for COPD pharmacological trials: from lung function to biomarkers
|European Respiratory Journal|2008|856
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
|European Respiratory Journal|2017|679
Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD
|New England Journal of Medicine|2014|621